Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Samorita HospitalDHA:SAMORITA +0.97%18 5-Year Yield-on-Cost % is 0.53 as of Jul. 18, 2026. GuruFocus rates DHA:SAMORITA with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 280 Healthcare Providers & Services companies, Samorita Hospital ranks worse than 88.57% on this metric.
Samorita Hospital's yield on cost for the quarter that ended in . 20 was 0.53.
The historical rank and industry rank for Samorita Hospital's 5-Year Yield-on-Cost % or its related term are showing as below:
DHA:SAMORITA'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0.76
Current: 0.53
During the past 0 years, Samorita Hospital's highest Yield on Cost was 0.76. The lowest was 0.00. And the median was 0.00.
DHA:SAMORITA's 5-Year Yield-on-Cost % is ranked worse than 88.57% of 280
companies
in the Healthcare Providers & Services industry
Industry Median: 2.93
vs DHA:SAMORITA: 0.53
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Samorita Hospital 5-Year Yield-on-Cost % Related Terms
DHA:SAMORITA vs SPIN, USNU, CHCR: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Samorita Hospital's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Samorita Hospital 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Samorita Hospital's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Samorita Hospital's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Samorita Hospital (DHA:SAMORITA) has a 5-Year Yield-on-Cost % of 0.53 as of Jul. 18, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Samorita Hospital and its competitors. According to the industry distribution chart, Samorita Hospital ranks #248 out of 280 companies in the Healthcare Providers & Services industry, placing it in the top 88.6%.
Is Samorita Hospital's 5-Year Yield-on-Cost % too high?
Samorita Hospital's current 5-Year Yield-on-Cost % is 0.53. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.93. Samorita Hospital's value of 0.53 is 81.9% below this industry median. Based on the distribution chart, Samorita Hospital ranks #248 out of 280 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Samorita Hospital has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Samorita Hospital's 5-Year Yield-on-Cost % compare to SPIN and USNU?
According to the Healthcare Providers & Services industry distribution chart, Samorita Hospital ranks #248 out of 280 companies for 5-Year Yield-on-Cost %. This places Samorita Hospital in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.93. Samorita Hospital's value of 0.53 is 81.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.93, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Samorita Hospital's current 5-Year Yield-on-Cost % of 0.53 is 81.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Samorita Hospital and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Samorita Hospital's current 5-Year Yield-on-Cost % is 0.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Samorita Hospital stock overvalued right now?
Samorita Hospital (DHA:SAMORITA) has a current 5-Year Yield-on-Cost % of 0.53. The current 5-Year Yield-on-Cost % is 0.53 and 81.9% below the Healthcare Providers & Services industry median of 2.93. Samorita Hospital's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Samorita Hospital (DHA:SAMORITA), the current 5-Year Yield-on-Cost % is 0.53 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Samorita Hospital Ltd provides general hospital services including all types of medical treatment along with diagnostic services in Bangladesh. It offers various clinical services in the areas of internal medicine, neurology, diabetes and endocrinology, nephrology, respiratory medicine, gastroenterology and other.
18GF Score
Get the complete analysis for DHA:SAMORITA
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:SAMORITA has been successfully added to your 
